reNEW

Market Access

One area where the Novo Nordisk Foundation has invested quite heavily is in cell therapy, especially stem cell research.

News

A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.